| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |